In a rare tame week for key economic data it is Thursday’s job figures that clearly stands out.

We look at two stocks in the IIR Pharma & Biotech Index that were the best performers in the top 10, both increasing over 40% for the month on the back of promising developments for their respective products.

Peter Switzer is joined by REA Group's Nerida Conisbee, Century 21's Charles Tarbey and Destiny Financial Solutions' Margaret Lomas.

We need to get off our butts and think like we’ve never thought before about ways to get out of this Coronavirus economic crisis. And here are some opening thoughts and ideas.

Is it time to buy the dips or are Tesla and tech stocks doomed?

These two Aussie companies are ‘oldies’ but are they ‘goodies’? When Jun Bei Liu was asked about Telstra (our 45-year-old telecommunications company) and AMP (our 171-year-old insurance house), here’s what she said…

The overlooked small cap champions defying the Coronavirus gloom.

Let’s look at CSL, Fisher & Paykel Healthcare, Cochlear, Resmed and Ansell.

Peter Switzer speaks to The Australia Institute chief economist Richard Denniss, plus the founder and CEO of Gilmour Space Technologies, Adam Gilmour, and the co-founder of Emma and Tom's, Tom Griffith.